EUVIMEDEUVIMED entdecken
Crossref

Expression of p53 and Rb reveal subtypes of gastric neuroendocrine carcinoma with distinct prognosis

Jiazhang Xing iD, Jingci Chen, Tingting You iD, Zhao Sun, Tao Lu, Yuejuan Cheng, Huanwen Wu, Chunmei Bai

Journal of Neuroendocrinology · 2023

DOI: 10.1111/jne.13257 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neuroendocrinology, 2023. Verfasst von Jiazhang Xing und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China. Hauptthemen laut MEDLINE: Carcinoma, Neuroendocrine, Neuroendocrine Tumors, Stomach Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Chinese Academy of Medical Sciences Initiative for Innovative Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastric neuroendocrine carcinoma (NEC) is a rare tumor with a poor prognosis. Due to its rarity and disparity in prevalence across populations, there is limited data on gastric NEC. TP53 and RB1 genetic alterations or expression were reported for predictive value in neuroendocrine neoplasm and classification in pulmonary large cell NEC. This study investigated the genetic alteration and protein expression of TP53 and RB1 in gastric NEC. Thirty‐nine patients were categorized as type A and B subtypes by p53 and Rb expression. Patients with concurrent abnormal p53 and Rb expression were defined as the type A group, and the remainder were defined as the type B group. Significant differences in TNM stages, tumor size, and lymph node metastasis were observed between the two subtypes. Type A characteristic is an independent predictor for worse overall survival (HR: 3.27; 95% CI: 1.12–9.58; p = .022). We further evaluated and compared immunotherapy‐related markers, including PD‐L1 expression, CD8 T cell infiltration, tumor mutation burden, and microsatellite instability in these two subtypes, whereas no significant differences were detected.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, NeuroendocrineNeuroendocrine TumorsStomach NeoplasmsHumansPrognosisTumor Suppressor Protein p53Retinoblastoma Protein

Stichwörter der Autor:innen

Rbneuroendocrine carcinomap53subtypes

Substanzen

Tumor Suppressor Protein p53Retinoblastoma Protein

Autor:innen und Institutionen

  • Department of Medical Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
  • Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.

ORCID-Profile: Jiazhang Xing, Tingting You

Förderung

  • Chinese Academy of Medical Sciences Initiative for Innovative Medicine

Zitieren

APA

Xing, J., Chen, J., You, T., Sun, Z., Lu, T., Cheng, Y., Wu, H., & Bai, C. (2023). Expression of p53 and Rb reveal subtypes of gastric neuroendocrine carcinoma with distinct prognosis. Journal of Neuroendocrinology. https://doi.org/10.1111/jne.13257

Vancouver

Xing J, Chen J, You T, Sun Z, Lu T, Cheng Y, et al. Expression of p53 and Rb reveal subtypes of gastric neuroendocrine carcinoma with distinct prognosis. Journal of Neuroendocrinology. 2023. doi:10.1111/jne.13257

BibTeX
@article{Xing2023,
  author = {Xing, Jiazhang and Chen, Jingci and You, Tingting and Sun, Zhao and Lu, Tao and Cheng, Yuejuan and Wu, Huanwen and Bai, Chunmei},
  title = {Expression of p53 and Rb reveal subtypes of gastric neuroendocrine carcinoma with distinct prognosis},
  journal = {Journal of Neuroendocrinology},
  year = {2023},
  doi = {10.1111/jne.13257}
}
Kostenlos starten →